Organic hybrid of chlorinated polyethylene and hindered phenol. II. Influence of the chemical structure of small molecules on viscoelastic properties

2000 ◽  
Vol 38 (11) ◽  
pp. 1496-1503 ◽  
Author(s):  
Chifei Wu ◽  
Tada-Aki Yamagishi ◽  
Yoshiaki Nakamoto ◽  
Shin-Ichiro Ishida ◽  
Saburo Kubota ◽  
...  
Keyword(s):  
Small Molecules ◽  
Viscoelastic Properties ◽  
Chemical Structure ◽  
Chlorinated Polyethylene ◽  
Organic Hybrid ◽  
Hindered Phenol

Dynamic properties of an organic hybrid of chlorinated polyethylene and hindered phenol compound

2001 ◽  
Vol 82 (7) ◽  
pp. 1788-1793 ◽  
Author(s):  
Chifei Wu ◽  
Yoshio Otani ◽  
Norikazu Namiki ◽  
Hitoshi Emi ◽  
Koh-Hei Nitta ◽  
...  
Keyword(s):  
Dynamic Properties ◽  
Chlorinated Polyethylene ◽  
Organic Hybrid ◽  
Phenol Compound ◽  
Hindered Phenol

scholarly journals Viscoelastic Properties of Organic Hybrids Consisting of Chlorinated Polyethylene and Hindered Phenol.

2000 ◽  
Vol 57 (5) ◽  
pp. 294-299 ◽  
Author(s):  
Chifei Wu ◽  
Tadaaki YAMAGISHI ◽  
Yoshiaki NAKAMOTO ◽  
Shinihiro ISHIDA ◽  
Kohhei NITTA ◽  
...  
Keyword(s):  
Viscoelastic Properties ◽  
Chlorinated Polyethylene ◽  
Hindered Phenol

Viscoelastic properties of an organic hybrid of chlorinated polyethylene and a small molecule

2000 ◽  
Vol 38 (10) ◽  
pp. 1341-1347 ◽  
Author(s):  
Chifei Wu ◽  
Tada-Aki Yamagishi ◽  
Yoshiaki Nakamoto ◽  
Shin-Ichiro Ishida ◽  
Koh-Hei Nitta ◽  
...  
Keyword(s):  
Small Molecule ◽  
Viscoelastic Properties ◽  
Chlorinated Polyethylene ◽  
Organic Hybrid

Effect of chemical structure and concentration of plasticizers on viscoelastic properties of SKN-26M

1987 ◽  
Vol 29 (8) ◽  
pp. 1888-1894
Author(s):  
I.I. Perepechko ◽  
V.P. Kuz'min ◽  
A.A. Dontsov ◽  
T.V. Litvinova
Keyword(s):  
Viscoelastic Properties ◽  
Chemical Structure

scholarly journals The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules ◽  
2020 ◽  
Vol 25 (3) ◽  
pp. 745 ◽  
Author(s):  
Beatriz G. de la Torre ◽  
Fernando Albericio
Keyword(s):  
Natural Products ◽  
Pharmaceutical Industry ◽  
Small Molecules ◽  
Chemical Structure ◽  
New Drugs ◽  
Antibody Drug Conjugates ◽  
Drug Conjugates ◽  
The Us ◽  
New Chemical Entities ◽  
Antibody Drug

During 2019, the US Food and Drug Administration (FDA) approved 48 new drugs (38 New Chemical Entities and 10 Biologics). Although this figure is slightly lower than that registered in 2018 (59 divided between 42 New Chemical Entities and 17 Biologics), a year that broke a record with respect to new drugs approved by this agency, it builds on the trend initiated in 2017, when 46 drugs were approved. Of note, three antibody drug conjugates, three peptides, and two oligonucleotides were approved in 2019. This report analyzes the 48 new drugs of the class of 2019 from a strictly chemical perspective. The classification, which was carried out on the basis of chemical structure, includes the following: Biologics (antibody drug conjugates, antibodies, and proteins); TIDES (peptide and oligonucleotides); drug combinations; natural products; and small molecules.

Sign in / Sign up

Export Citation Format

Share Document